NCT04824859

Brief Summary

This project assesses the feasibility and usability of the geriatric assessment platform (electronic Geriatric Assessment Platform or eGAP in 50 older patients with cancer, their caregivers, and their oncology team. Using an iterative process, we will refine the eGAP based on input from stakeholders.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable cancer

Timeline
Completed

Started Dec 2021

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

December 7, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2023

Completed
Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

1.4 years

First QC Date

March 27, 2021

Last Update Submit

December 31, 2025

Conditions

Cancer

Keywords

Supportive CareCancermHealthGeriatric

Outcome Measures

Primary Outcomes (1)

  • Feasibility Retention Rate

    Percentage of patients completing the assessments that are assigned to them on eGAP

    1 week

Secondary Outcomes (3)

  • Recruitment rates

    1 week

  • Self-Report Completion Time

    1 week

  • System Usability Scale

    1 week

Study Arms (1)

Experimental

EXPERIMENTAL

The eGAP consists of validated questionnaires that are used to assess health status of older adults with cancer. Based on patient responses, tailored recommendations will be provided.

Behavioral: Behavioral

Interventions

BehavioralBEHAVIORAL

eGAP that allows patients to complete validated questionnaires, and these questionnaires will be summarized and recommendations provided to the treating team

Experimental

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥65 years
  • Have a diagnosis of cancer
  • Able to provide informed consent
  • English-speaking (because the platform is currently in English)
  • Age ≥21 years
  • Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters".
  • Able to provide informed consent
  • English-speaking
  • Oncologists, APPs, and nurses who care for the patient

You may not qualify if:

  • N/A

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Rochester

Rochester, New York, 14642, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Kah Poh Loh

    University of Rochester

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: Electronic geriatric assessment platform to collect data (e.g., functional status, comorbidity, psychological health) that may better reflect health status of older adults with cancer
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor - Department of Medicine, Hematology/Oncology (SMD)

Study Record Dates

First Submitted

March 27, 2021

First Posted

April 1, 2021

Study Start

December 7, 2021

Primary Completion

April 30, 2023

Study Completion

April 30, 2023

Last Updated

January 5, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

A complete and final study protocol will be made publicly available through the University of Rochester Cancer Center Community Oncology Research Program Research Base Protocol and Data Sharing Committee. The full protocol and data will be made publicly available no later than the publication date of the study findings from the final dataset. The protocol will include a detailed description of the study population, hypotheses tested, measurement and assessment information, data definitions and codes, and the analysis plan utilized. We will be collecting identifying information. The final dataset will be stripped of identifiers prior to release for sharing. Published papers will be made available in portable document format.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will be available for 7 years from accrual of the first subject.

Locations

US(1)